ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

7,272Medicare Part D Prescriptions Filled, Including Refills

Rank: 265 out of 973

$457K Total Retail Price of All Prescriptions

Rank: 176 out of 973

247 Patients Receiving at Least One Drug in Part D
77%Patients 65 Years and Older
60% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Kansas
Lower avg

Schedule Two
Controlled Substances

9% of this provider’s 247 patients filled at least one prescription for a schedule two drug, compared to an average of 6%.

Schedule Three
Controlled Substances

16% of this provider’s 247 patients filled at least one prescription for a schedule three drug, compared to an average of 14%.

Risky Drugs to Seniors

1% of this provider’s 5,497 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

28% of this provider’s prescriptions were for brand-name drugs, compared to an average of 22%.

Prescription Price

$63 was the average price of a prescription from this provider, compared to $51 among peers.

Prescriptions per Patient

29 is the average number of prescriptions (including refills) per patient, compared to an average of 21.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Kansas
LEVOTHYROXINE SODIUM 324 277 1 2
OMEPRAZOLE 289 241 2 5
FUROSEMIDE 222 196 3 6
HYDROCODONE-ACETAMINOPHEN 189 124 S3 4 4
SIMVASTATIN 155 124 5 1
POTASSIUM CHLORIDE 137 132 6 9
LISINOPRIL 127 107 7 3
GABAPENTIN 126 63 8 12
NAMENDA 112 112 9 31
CITALOPRAM HBR 110 90 10 14
METOPROLOL SUCCINATE 108 82 11 17
ZOLPIDEM TARTRATE 105 77 12 20
CYMBALTA 104 49 13 40
LOSARTAN POTASSIUM 101 97 14 19
ATORVASTATIN CALCIUM 94 64 15 15
ALLOPURINOL 93 71 16 29
ADVAIR DISKUS 92 82 17 60
CIPROFLOXACIN HCL 91 80 18 57
AMLODIPINE BESYLATE 89 79 19 7
TRAMADOL HCL 85 65 20 18
PAROXETINE HCL 85 79 20 66
ATENOLOL 81 81 22 16
ALENDRONATE SODIUM 81 72 22 24
PANTOPRAZOLE SODIUM 79 49 24 37
KLOR-CON M20 75 47 25 64
PREDNISONE 74 58 26 33
SPIRIVA 66 66 27 73
DONEPEZIL HCL 58 51 28 26
WARFARIN SODIUM 58 58 28 10
PROAIR HFA 57 25 30 54
DILTIAZEM 24HR CD 56 53 31 104
SYMBICORT 55 44 32 163
MELOXICAM 55 36 32 23
METFORMIN HCL ER 55 36 32 58
EVISTA 53 53 35 121
CELEBREX 52 44 36 91
FAMOTIDINE 52 49 36 61
ISOSORBIDE MONONITRATE ER 51 45 38 85
NEXIUM 51 19 38 30
PRAVASTATIN SODIUM 50 41 40 22
CLOPIDOGREL 50 50 40 44
JANUVIA 50 29 40 88
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Feb. 17, 2011.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.